Stockreport

Oculis Reports Q3 2025 Financial Results and Provides Company Update

Oculis Holding AG - Ordinary shares  (OCS) 
PDF Oculis accelerates its portfolio development with Privosegtor moving into the PIONEER pivotal program in Acute Optic Neuritis (AON) and Non-arteritic Anterior Ischemic O [Read more]